Fingerprint
Dive into the research topics of 'BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically